eSymposia | Tuberculosis: Science Aimed at Ending the Epidemic
Short Talk: The Next Generation Diarylquinoline TBAJ 587 has Superior Efficacy Against, and Restricts Selection of, Bedaquiline Resistant Rv0678 Mutants in a Mouse Model of Tuberculosis
Dec 4, 2020 12:24pm ‐ Dec 4, 2020 12:36pm
Paul J. Converse
, PhD, Johns Hopkins University
You must be logged in and own this session in order to post comments.
© 2022 Keystone Symposia & Digitell, Inc. All Rights Reserved